About this document
165 JMSCR by Adeel Belim is a document available to read on EtoBox.
The study evaluates the clinical outcomes of 128 patients who underwent coronary artery stenting with Xience V everolimus eluting stents for coronary artery disease. Results showed low rates of adverse outcomes, with 2.3% mortality, 4.7% experiencing myocardial infarction, and 9.4% having major adverse cardiac events after one year. The findings align with previous randomized trials, indicating the effectiveness of Xience V stents in real-world settings.
- Author
- Adeel Belim
- Language
- EN